Piperacillin-Sulbactam
- Generic Name
- Piperacillin-Sulbactam
Overview
No overview information available.
Background
No background information available.
Indication
敏感细菌所致的全身和（或）局部细菌感染。如⑴呼吸系统感染：包括急性支气管炎、肺炎、慢性支气管炎急性发作、支气管扩张合并感染等。 ⑵泌尿系统感染：包括单纯性泌尿系统感染和复杂型泌尿系统感染。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字H20153074 | 注射剂 | N/A | 1.25g（哌拉西林1.0g与舒巴坦0.25g） | Chemical Drug | Approved | 2020/03/02 | Domestic | ||
国药准字H20213880 | 注射剂 | N/A | 1.25g(C23H27N5O7S 1.0g与C8H11NO5S 0.25g) | Chemical Drug | Approved | 2021/11/24 | Domestic | ||
国药准字H20213881 | 注射剂 | N/A | 2.5g(C23H27N5O7S 2.0g与C8H11NO5S 0.5g) | Chemical Drug | Approved | 2021/11/24 | Domestic | ||
国药准字H20050338 | 注射剂(无菌分装粉针剂) | N/A | 1.25g(含哌拉西林1.0g与舒巴坦0.25g) | Chemical Drug | Approved | 2020/02/08 | Domestic | ||
国药准字H20060431 | 注射剂(无菌分装粉针剂) | N/A | 2.5g[含哌拉西林钠按哌拉西林(C23H27N5O7S)计为2.0g,含舒巴坦钠按舒巴坦(C8H11NO5S)计算为0.5g] | Chemical Drug | Approved | 2020/02/08 | Domestic | ||
国药准字H20103093 | 注射剂 | N/A | 5.0g[含哌拉西林钠按哌拉西林(C23H27N5O7S)计为4.0g,含舒巴坦钠按舒巴坦(C8H11NO5S)计算为1.0g] | Chemical Drug | Approved | 2020/02/07 | Domestic | ||
国药准字H20153075 | 注射剂 | N/A | 2.5g（哌拉西林2.0g与舒巴坦0.5g） | Chemical Drug | Approved | 2020/03/02 | Domestic | ||
国药准字H20193168 | 注射剂 | N/A | 2.5g (C23H27N5O7S 2.0g与 C8H11NO5S 0.5g) | Chemical Drug | Approved | 2019/06/10 | Domestic | ||
国药准字H20193167 | 注射剂 | N/A | 1.25g(C23H27N5O7S 1.0g与 C8H11NO5S 0.25g) | Chemical Drug | Approved | 2019/06/10 | Domestic | ||
国药准字H20193169 | 注射剂 | N/A | 1.5g(C23H27N5O7S 1.0g与 C8H11NO5S 0.5g) | Chemical Drug | Approved | 2019/06/10 | Domestic |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath